Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Heather E Stefanski

Showing results (11-20 of 53) with videos related to

Pageof 6
Sort By:
Blood|April 19, 2011
Mouse Ly49G2+ NK cells dominate early responses during both immune reconstitution and activation independently of MHCIsabel Barao, Maite Alvarez, Erik Ames, et al.
Pediatric Blood & Cancer|November 16, 2012
Early hematopoietic stem cell transplant is associated with favorable outcomes in children with MDSAngela R Smith, Ellen C Christiansen, John E Wagner, et al.
Transplantation and Cellular Therapy|November 28, 2025
Genetic Findings of Potential Donor Origin in Cells Used for Cell and Gene Therapy: Recommendations from the World Marrow Donor AssociationAngharad Pryce, Meghann Cody, Abeer Madbouly, et al.
Blood Advances|April 10, 2023
Clinical impact of cryopreservation of allogeneic hematopoietic cell grafts during the onset of the COVID-19 pandemicSteven M Devine, Stephanie Bo-Subait, Michelle Kuxhausen, et al.
Transplantation and Cellular Therapy|February 22, 2023
A Multicenter Phase 2 Clinical Trial of 10-Day Decitabine, Dose-Escalated Donor Lymphocyte Infusion, and Ruxolitinib for Relapsed Acute Myeloid Leukemia and Myelodysplastic Syndromes after Allogeneic Hematopoietic Cell TransplantationArmin Rashidi, Eric J Huselton, Heather E Stefanski, et al.
Blood Advances|July 21, 2025
A Simple and Efficient Method for the Robust Expansion of Human ILC2s to Prevent Acute GvHDDanny W Bruce, Sonia J Laurie, Yan Xing, et al.
Plos One|January 25, 2022
P63 targeted deletion under the FOXN1 promoter disrupts pre-and post-natal thymus development, function and maintenance as well as induces severe hair lossHeather E Stefanski, Yan Xing, Jemma Nicholls, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 6, 2024
Reply to: Disparities in Allograft Access in the Era of Post-Transplant Cyclophosphamide-Based Mismatched Unrelated Donor TransplantationBrian C Shaffer, Mahasweta Gooptu, Todd DeFor, et al.
Journal of Immunology (Baltimore, Md. : 1950)|October 31, 2018
Thymic Epithelial Cell Support of Thymopoiesis Does Not Require <i>Klotho</i>Yan Xing, Michelle J Smith, Christine A Goetz, et al.
Frontiers in Immunology|October 7, 2022
Neither COVID-19, nor cryopreservation, prevented allogeneic product infusion: A report from the National Marrow Donor ProgramNosha Farhadfar, Jeni Newman, Jennifer Novakovich, et al.
Pageof 6

Showing results (11-20 of 53) with videos related to

Sort By:
Pageof 6
Blood|April 19, 2011
Mouse Ly49G2+ NK cells dominate early responses during both immune reconstitution and activation independently of MHCIsabel Barao, Maite Alvarez, Erik Ames, et al.
Pediatric Blood & Cancer|November 16, 2012
Early hematopoietic stem cell transplant is associated with favorable outcomes in children with MDSAngela R Smith, Ellen C Christiansen, John E Wagner, et al.
Transplantation and Cellular Therapy|November 28, 2025
Genetic Findings of Potential Donor Origin in Cells Used for Cell and Gene Therapy: Recommendations from the World Marrow Donor AssociationAngharad Pryce, Meghann Cody, Abeer Madbouly, et al.
Blood Advances|April 10, 2023
Clinical impact of cryopreservation of allogeneic hematopoietic cell grafts during the onset of the COVID-19 pandemicSteven M Devine, Stephanie Bo-Subait, Michelle Kuxhausen, et al.
Transplantation and Cellular Therapy|February 22, 2023
A Multicenter Phase 2 Clinical Trial of 10-Day Decitabine, Dose-Escalated Donor Lymphocyte Infusion, and Ruxolitinib for Relapsed Acute Myeloid Leukemia and Myelodysplastic Syndromes after Allogeneic Hematopoietic Cell TransplantationArmin Rashidi, Eric J Huselton, Heather E Stefanski, et al.
Blood Advances|July 21, 2025
A Simple and Efficient Method for the Robust Expansion of Human ILC2s to Prevent Acute GvHDDanny W Bruce, Sonia J Laurie, Yan Xing, et al.
Plos One|January 25, 2022
P63 targeted deletion under the FOXN1 promoter disrupts pre-and post-natal thymus development, function and maintenance as well as induces severe hair lossHeather E Stefanski, Yan Xing, Jemma Nicholls, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 6, 2024
Reply to: Disparities in Allograft Access in the Era of Post-Transplant Cyclophosphamide-Based Mismatched Unrelated Donor TransplantationBrian C Shaffer, Mahasweta Gooptu, Todd DeFor, et al.
Journal of Immunology (Baltimore, Md. : 1950)|October 31, 2018
Thymic Epithelial Cell Support of Thymopoiesis Does Not Require <i>Klotho</i>Yan Xing, Michelle J Smith, Christine A Goetz, et al.
Frontiers in Immunology|October 7, 2022
Neither COVID-19, nor cryopreservation, prevented allogeneic product infusion: A report from the National Marrow Donor ProgramNosha Farhadfar, Jeni Newman, Jennifer Novakovich, et al.
Pageof 6